The company LabMD finally won its six-year battle with the FTC, but vindication came too late. Sometimes winning is still losing. That is certainly true for companies that find themselves caught in the cross hairs of the federal government. Since 2013, my organization has defended one such company, the cancer-screening LabMD, against